chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a nurse via sales rep and described the occurrence of cold sores in a 50-year-old female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced cold sores. On an unknown date, the outcome of the cold sores was unknown. It was unknown if the reporter considered the cold sore to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient was a nurse. The patient was vaccinated at the health department.
9/25/09 16:35 within 30 minutes left outer eye felt heavy and was itching. Spoke to person who stated this was one of the reactions to AFLURIA vaccine. I spoke to Dr. who stated, no concern. Color will go from red->blue->red last 3 weeks. It is a glaucoma hemorrhage. One hour later started with right and left deltoid pain 0-10 "5 lasted 2 days." PCM Dr. have not seen provider or received treatment for symptoms only verbal advice. "No longer have R/L deltoid pain but concerned about L red eye. Spot under iris in white area (sclera). Patient notified to follow up with provider for care. Patient agreed and understood.
Patient received vaccination and upon looking at the bandage saw a drop of blood and passed out. The patient did warn the pharmacist that this was going to happen because she stated it happens every time. Patient was kept upright in chair due to lack of room to move to floor. Airway was maintained, pulse was monitored, cold compress was applied, patient regained consciousness in less than 60 sec. remained on site for approximately 30 minutes and drank water and ate crackers until feeling well
Patient bled after injection was given and developed small hematoma at injection site.  Patient was not in pain and bleeding was stopped in less than minute, but had a bump/bruise at injection site.
"Received vaccine around 9:30am without any initial reaction. Around 9:30pm developed rigors felt cold no fever went to bed and rigors subsided after 20 minutes. Body did ache overnight and headache developed. Took Tylenol with some relief. In am aches and rigors remained absent but still had dull headache. Took headache  medicine and otherwise felt fine. I have a history of feeling like this in the past after receiving my flu shot."
Symptoms for Moderna's COVID-19 vaccine: Day 1: pain on site of vaccine/feverish/headache/felt delirious; Day 2: arm, neck & chest pain on side of vaccine/headache/feverish with chills & body aches/headache persists; Day 3: Much improved; arm still stiff and sore; all other symptoms absence.
Information has been received from a licensed practical nurse (L.P.N.) concerning a 23 year old female with no pertinent medical history and no known drug allergies who on 02-NOV-2007, 17-JAN-2008 and 16-MAY-2007, was vaccinated intramuscularly with her first, second and third 0.5 ml doses, respectively, of GARDASIL (Lot # of the first dose 659435/1265U, Lot # of the second dose of 558282/1263U, Lot # of the third dose 658490/0802U). There was no concomitant medication. On 16-MAY-2008, after receiving the third dose GARDASIL, the patient became warm and sweaty. She fainted and was unconscious for 45 seconds. The patient had only eaten fruit prior to administration of GARDASIL. Subsequently, on 16-MAY-2008 the patient recovered from the events. The adverse events happened during office visit. This is one of several reports from the same source. Additional information has been requested.
Background information Dose 3: Moderna -Full dose, 08/28/2021. A month in half later gallbladder attack.  Transported to the hospital initially for first visit and stayed until 03:00 AM . Did test and found nothing, told her take peptide for stomachache. CAT and Ultrasound.  Few days later, patient's spouse took to hospital emergency room and was admitted the next morning. Ultimately, admitted to hospital and gallbladder was removed.  Pain after operation and liver function numbers was high.  In operation, the stone was found with a lot of slug that was unexpected. Into of the stone. Had to stay in hospital a little longer to get slug out of the ducks. 7 days hospital stay.
Fever,SkinRash, maculopapular rash over torso, arms, legs, neck, right periorbital edema; pruritis Narrative: 3rd injection: "left arms delayed reaction with fever 101.5; maculopapular rash over torso, arms, legs, neck, some eye edema. Pruritis was ongoing; no markedly reduced:
Systemic: Rash (other than injection site)-Mild, Systemic: Nausea-Severe, Systemic: Vertigo-Severe
Information has been received from a physician concerning a 4 year old female who on 17 November 2003, was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) ( lot # 642683/0326M). There was no concomitant medication. In November 2005, the patient developed a mild break through case of chickenpox. The case was so mild, the mother did not bring it to her physician's attention at the time. A product complaint was not involved. Additional information has been requested. The patient's brother had a similar experience after therapy with varicella virus vaccine live (Oka/Merck) (WASE # 0602USA04774).
3/30/88 p/ DTP & OPV #1, pt T101-103; screaming; large reddish purple whelp at inj site; limpness in neck; stiffening arms & legs were shaking; lethargic;
On July 6th I began to feel mild congestion.  The next day I had fatigue and low grade fever and sore throat.  We tested positive for COVID-19 with PCR test at the clinic.  Fever was gone in two days.  Congestion lasted about 4 days.  Fatigue lasted another 5 days.  On Friday the 8th we had the virtual appointment and got the MAB infusion.  As of today I feel fine with a bit of afternoon fatigue.  I just don't have the endurance I had before.
Vertigo, loss of balance on trying to stand, dizziness, nausea, vomiting, pressure in the left ear, throbbing of left ear, unable to turn head without bringing on dizziness, eye throbbing.
Painful lump on arm that has turned red and itches when she pressed on it/as a site reaction; Painful lump on arm that has turned red and itches when she pressed on it/as a site reaction; Painful lump on arm that has turned red and itches when she pressed on it/as a site reaction; It seemed that it had persisted longer and he said it sounded like it was getting infected; it was painful almost immediately/as a site reaction; This is a spontaneous report from a contactable nurse (patient) via Pfizer Sales Representative. A 51-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date unknown), via an unspecified route of administration on 28Dec2020 injected in unknown arm at single dose for precaution as a front line healthcare worker in hospital. The patient's medical history and concomitant medications were not reported. In the last 9 months, she worked in the COVID unit. It was unknown if additional vaccines administered on same date of bnt162b2. Prior vaccinations within 4 weeks was unknown. Patient said she got the bnt162b2 through her hospital on 28Dec2020, and still had a painful lump on arm that had turned red and itches when she pressed it was reported as worsened on 28Dec2020, it was painful almost immediately, like you would normally get with any vaccination. It seemed that it had persisted longer and he (Sales Representative) said it sounded like it was getting infected. She said it was painful when she pressed on it and he told her not to press on it. Compared to when she had gotten other vaccines in the arm, this seemed out of the ordinary for how long it had been painful as a site reaction. No ER or physician's office required. The outcome of the events was not recovered.  Information on lot/batch number has been requested.
I have gotten the shingles vaccine and I'm glad I did but a week ago I developed shingles/suspected vaccination failure; I have gotten the shingles vaccine and I'm glad I did but a week ago I developed shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In JUL-2023, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I have gotten the shingles vaccine and I'm glad I did but a week ago I developed shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I have gotten the shingles vaccine and I'm glad I did but a week ago I developed shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 24-JUL-2023 This case was reported by a patient via interactive digital media. The patient had gotten the shingles vaccine and he/she was glad that he/she did but a week ago he/she developed shingles in My eye like in his/her internal lie and it really sucks but he/she was glad that he/she got the shingles vaccine cause he/she could only imagine what this would be like if he/she had not had gotten it. This case was considered as suspected vaccination failure as details regarding primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Extreme swelling, redness of the injection site. Headache, High Fever (101.6 - 102 degrees), Neck stiffness, Chills, Dizziness, Nausea
Pt received his sister HPV. 0.3 ML.  He was to get the flu - no adverse reactions at time of immuz.
7 days after treatment, injection site became quite erythematous, indurated, and pruritic.  resolved with a few antihistamines w/in 24 hours.  possible delayed hypersensitivity reaction?  i have prednisone and an Epi Pen on hand for shot #2 just in case
PATIENT REFERS DIZZINESS WITH WEAKNESS, CHILL AND PALENESS. DIDN'T EAT ANYTHING FOR A WHILE BEFORE VACCINATION.
Drew up diluent, did not mix with powder. Error caught while drawing up other vaccines. Diluent mixed with powder after realizing error.
medical assistant reported that a 12 year old female patient accidentally received a dose of Infanrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-year-old female patient who received DTPa (Infanrix) (batch number 9HP9Z, expiry date 21-APR-2024) for prophylaxis.   On 23-OCT-2023, the patient received Infanrix. On 23-OCT-2023, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: medical assistant reported that a 12 year old female patient accidentally received a dose of Infanrix). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 23-Oct-2023 The reporter consented to follow-up via email. The patient received a dose of Infanrix at an inappropriate age, which led to inappropriate age at vaccine administration.
had sore throat the day p/vax w/ flu shot;had an elevated temp yesterday but not as bad as wife's rxn;advised to see PMD
This spontaneous case reported by a consumer, describes the occurrence of urticaria (hives), pain in extremity (arm soreness), chills and pyrexia (fever) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 001B21A) for COVID-19 vaccination. No medical history reported. On Mar 16, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 14, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 14, 2021, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced pain in extremity (arm soreness). On May 31, 2021, patient experienced urticaria (hives), chills and pyrexia (fever). The patient treated with Tylenol (paracetamol) for pain in extremity, chills and fever; at an unspecified dose and frequency. On May 31, 2021, pain in extremity (arm soreness) resolved. At the time of the report, urticaria (hives), chills and pyrexia (fever) outcome: unknown. Concomitant medications not reported.
c/o of feeling nauseated accompanied by h/a approx 1 hr; kind of numb inject site felt slightly hot to touch per pt; lethargic;
Severely swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) via an unspecified route of administration in the left arm on 23Mar2021 at 13:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) via an unspecified route of administration in the left arm on 02Mar2021 at 13:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. On 25Mar2021 at 15:00, three days after the second dose patient had severely swollen lymph nodes. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event severely swollen lymph nodes was not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
<5min p/vax given flare 1/2" wheal, 2" below inj site-itching @ site;several hr later rt arm +swelling above elbow twice nl size w/serous seepage from swelling;sl tingling & numbness;pt did not see MD;
a dose of MMRII that was administered post expiry. HCP states the MMRII expired on 04AUG2023, and was administered 11AUG2023. HCP states the patient reports no side effects; HCP states the patient reports no side effects; This spontaneous report was received from a pharmacist concerning a patient of unknown age and gender.  On 11-AUG-2023 the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) albumin status: rHA (recombinant Human albumin), lot# U024229, expiry date: 04-AUG-2023 for prophylaxis (dose and route of administration were not provided) that was administered post expiry date (expired product administered). No side effects were reported by the patient. The product never experienced any temperature excursions.
Pain (R) shoulder at time of injection, has had persistent (R) shoulder, with radiation down side of (R) arm and decrease ROM of (R) shoulder.
Significant pain now lasting several months.  Pt initially unable to lift arm and area continues to be extremely sensitive to the touch.
Dizziness, Headache, Myalgia, Arthralgia,  INJECTION SITE PAIN  Narrative:   Other Relevant History:
I was down for 2 days after each injection. Miserable!; This case was reported by a consumer via interactive digital media and described the occurrence of feeling miserable in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling miserable. On an unknown date, the outcome of the feeling miserable was recovered/resolved.   It was unknown if the reporter considered the feeling miserable to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR084029   Additional Information: GSK Receipt Date: 23-May-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. the patient received 1st dose of Shingles vaccine and had reaction that could not be imagine what Shingles feels like. The patient was down for 2 days after 1st dose and it was miserable. Additional Supportive Information: For tolerance of 2nd dose of Shingles vaccine refer linked case US2022AMR084029, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR084029:Same Reporter
Swollen lymph nodes under left armpit; have lasted 2 day at time of reporting, slight pain/lot of swelling.
This spontaneous report as received from a physician via a field representative refers to a 79 years old female patient with trouble with hearing. The patient was vaccinated with 0.65 ml ZOSTAVAX (lot# was unknown) between April and August in 2012. The doctor reported "the patient was given vaccine by an unspecified HCP". The patient had preexisting trouble with hearing at the time of the vaccination". Between April and August 2012 "she was given the vaccine, and later that day she lost all her hearing". "The patient has recovered and her hearing was at the same level it was at before she got the vaccine". The representative stated that "the problem she had with hearing was a significant disability/incapacity". The patient sought medical attention and got unspecified steroid to treat the adverse event. Additional information has been requested.
24 hours after vaccine administration, red/hot area developed on lateral (L) at site of vaccine; grew to 18 x 18 cm, no fever, not tender.
Body aches, muscle aches, lethargic,  fever of 100.9  I took some Tylenol before bed and woke up in the middle of the night very sweaty. Feel fine the following morning
Reconstituted varicella vaccine w/Tdap & gave injection. Contacted dr & he stated child should be fine with on consequence.
6/5/18 - 6/10/18- general tiredness, 6/5/18- vomiting, 6/6/18- vomiting/diarrhea (stopped on 6/10/18), 6/5/18-6/10/18 - no appetite.
Information has been received from a registered nurse concerning a 10 year old male with an allergy to AMOXIL who on 09-AUG-2006 was vaccinated SC in the left arm with a first dose of Varivax (lot # 652725/0249R). Concomitant therapy included an over-the-counter allergy medication (unspecified). On 10-AUG-2006, within 24 hours of vaccination, the patient developed redness and swelling of about two centimeters. No medical attention was sought and the patient recovered from these events on 16-AUG-2006. It was also noted that the patient received an unspecified concomitant booster with 3.5 inches of redness for that injection and had more pain with the booster. The patient recovered from these events on an unspecified date. No further information is available. The patient's sibling had a similar experience after therapy with Varivax (WAES # 0608USA05445).
pt received vaccine on 26JUN07. In the evening of 29JUN07, he presented with urticaria including swelling of lower lip. He was given steroids and antihistamines and symptoms resolved. He returned again the following day with similiar episode minus the lip swelling and was encourage to continue to the antihistamines. Symptoms resolve in a couple of hours. He takes no meds. No new foods, bites etc. Its unclear if this could be related to vaccine
Terrible bone aches all over for 24 hours, big red hot itchy site for 2 weeks, headaches for 2 weeks, very loose stool several times, nausea for 2 days 1 week after shot.
Headache blurry vision to right eye that went away. sore and tired Narrative:
Pt seen 20 Feb 08 for persistent keloid-type lesions on both (R) and (L) anterior thighs. These lesions, one on each anterior thigh, measure approx. 5mm x 10mm, and appeared within a week of vaccination. ** This report relates to the injections given 21 Dec 07, which led to the lesion on the (L) thigh. ** A seperate report details injections given 31 Oct 07, related to the lesion in the (R) thigh.
chills, headache, muscle aches, nausea, tired, sharp shooting abdominal pains. Due to taking Meloxicam, I can't take other NSAIDS. I took Vicodin for the headache and muscle aches. By 5/8/16 a.m. all symptoms gone except for lingering headache which was gone by noon.
Redness, edema, tenderness, pruritus at site of injections. Developed one day after injections. + reported fever (by parents) Tm 102.4. Mom using ice packs, Motrin and Benadryl.
This was my first dose of Moderna: around 5 pm the same day I was experiencing fatigue and mild achiness. The next morning I woke up and couldn't move my head or neck from debilitating pain. I was not able to sit or stand on my own, and I could not walk more than a few steps without needing to sit down and rest. Severe upper back, neck and head pain for 3 days. Some intermittent irregular heartbeat, chest tightness as well. I lost 8 pounds (123lbs to 115lbs) in two days.
This case was reported by a consumer via call center representative and described the occurrence of aphthous stomatitis in a adult male patient who received SHINGRIX for prophylaxis. In June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced aphthous stomatitis, allergic reaction, fever, lip swelling, skin peeling, touch sensitivity increased, sores mouth, generalized rash and pruritus. On an unknown date, the outcome of the aphthous stomatitis was recovered/resolved and the outcome of the allergic reaction, fever, lip swelling, skin peeling, touch sensitivity increased, sores mouth, generalized rash and pruritus were unknown. It was unknown if the reporter considered the aphthous stomatitis, allergic reaction, fever, lip swelling, skin peeling, touch sensitivity increased, sores mouth, generalized rash and pruritus to be related to SHINGRIX. Additional details were reported as follows: The patient had a severe allergic reaction to the SHINGRIX shot. The patient experienced fever, swallowed lip, canker sores in the mouth, bumps internal and external on several parts of the body, skin peeling and send ivory to touch and some itching. The patient saw 3 doctors to assist in diagnosing the problem. The patient stated to contact at GSK's earliest convenience. The patient was not planning on a 2nd shot but need GSK's input. All symptoms were resolved within 10 days to 2 weeks.
Information has been received from a nurse concerning a female patient who was vaccinated with a 0.5 ml dose of HPV vaccine. Subsequently the patient fainted. Unspecified medical attention was sought. a short time after vaccination, the patient recovered. No product quality complaint was involved. Additional information has been requested.
first dose > 35 days ago; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first dose > 35 days ago) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3001658) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose > 35 days ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first dose > 35 days ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow-up information received on 23-JUL-2021 and contains non-significant information.